JENNIFER HOWIE: Open Payments
NPI 1194315440 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,805 in 89 payments from 18 companies in 2025. Trend: 2023 $388 · 2024 $2,219 · 2025 $2,805
Food & beverage: $2,805
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $484 |
| Novo Nordisk Inc | 15 | $426 |
| AstraZeneca Pharmaceuticals LP | 8 | $361 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $355 |
| ABBVIE INC. | 10 | $308 |
| Medtronic, Inc. | 5 | $169 |
| Phathom Pharmaceuticals, Inc. | 5 | $163 |
| Otsuka America Pharmaceutical, Inc. | 2 | $123 |
| Lundbeck LLC | 5 | $104 |
| PFIZER INC. | 4 | $69 |
Products named: Auvelity, Kerendia, Ozempic, REXULTI, AIRSUPRA, INTELLIS ADAPTIVESTIM, VOQUEZNA, VRAYLAR.
Industry payments across IN — which companies pay providers there.
